Mathew Bull1, Mei Methawasin1, Joshua Strom1, Pooja Nair1, Kirk Hutchinson1, Henk Granzier2. 1. From the Department of Cellular and Molecular Medicine (M.B., M.M., J.S., P.N., K.H., H.G.) and Sarver Molecular Cardiovascular Research Program (M.B., M.M., J.S., P.N., K.H., H.G.), University of Arizona, Tucson. 2. From the Department of Cellular and Molecular Medicine (M.B., M.M., J.S., P.N., K.H., H.G.) and Sarver Molecular Cardiovascular Research Program (M.B., M.M., J.S., P.N., K.H., H.G.), University of Arizona, Tucson. granzier@email.arizona.edu.
Abstract
RATIONALE: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. OBJECTIVE: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. METHODS AND RESULTS: Constitutive and inducible cardiomyocyte-specific RBM20-inhibited mice were produced on a Ttn(ΔIAjxn) background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band-A-band junction (IAjxn) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn(ΔIAjxn) mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. CONCLUSIONS: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.
RATIONALE: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. OBJECTIVE: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. METHODS AND RESULTS: Constitutive and inducible cardiomyocyte-specific RBM20-inhibited mice were produced on a Ttn(ΔIAjxn) background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band-A-band junction (IAjxn) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn(ΔIAjxn) mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. CONCLUSIONS: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.
Authors: Wei Guo; Sebastian Schafer; Marion L Greaser; Michael H Radke; Martin Liss; Thirupugal Govindarajan; Henrike Maatz; Herbert Schulz; Shijun Li; Amanda M Parrish; Vita Dauksaite; Padmanabhan Vakeel; Sabine Klaassen; Brenda Gerull; Ludwig Thierfelder; Vera Regitz-Zagrosek; Timothy A Hacker; Kurt W Saupe; G William Dec; Patrick T Ellinor; Calum A MacRae; Bastian Spallek; Robert Fischer; Andreas Perrot; Cemil Özcelik; Kathrin Saar; Norbert Hubner; Michael Gotthardt Journal: Nat Med Date: 2012-05 Impact factor: 53.440
Authors: Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald Journal: JAMA Date: 2013-03-27 Impact factor: 56.272
Authors: Michael H Radke; Jun Peng; Yiming Wu; Mark McNabb; O Lynne Nelson; Henk Granzier; Michael Gotthardt Journal: Proc Natl Acad Sci U S A Date: 2007-02-20 Impact factor: 11.205
Authors: Henk L Granzier; Michael H Radke; Jun Peng; Dirk Westermann; O Lynne Nelson; Katharina Rost; Nicholas M P King; Qianli Yu; Carsten Tschöpe; Mark McNabb; Douglas F Larson; Siegfried Labeit; Michael Gotthardt Journal: Circ Res Date: 2009-08-13 Impact factor: 17.367
Authors: Nicholas M P King; Methajit Methawasin; Joshua Nedrud; Nicholas Harrell; Charles S Chung; Michiel Helmes; Henk Granzier Journal: J Gen Physiol Date: 2011-01 Impact factor: 4.086
Authors: Sanjiv J Shah; Barry A Borlaug; Dalane W Kitzman; Andrew D McCulloch; Burns C Blaxall; Rajiv Agarwal; Julio A Chirinos; Sheila Collins; Rahul C Deo; Mark T Gladwin; Henk Granzier; Scott L Hummel; David A Kass; Margaret M Redfield; Flora Sam; Thomas J Wang; Patrice Desvigne-Nickens; Bishow B Adhikari Journal: Circulation Date: 2020-03-23 Impact factor: 29.690
Authors: Martin Liss; Michael H Radke; Jamina Eckhard; Martin Neuenschwander; Vita Dauksaite; Jens-Peter von Kries; Michael Gotthardt Journal: PLoS One Date: 2018-06-11 Impact factor: 3.240
Authors: Rebecca E Slater; Joshua G Strom; Mei Methawasin; Martin Liss; Michael Gotthardt; Nancy Sweitzer; Henk L Granzier Journal: J Gen Physiol Date: 2018-12-19 Impact factor: 4.086
Authors: Charles A Tharp; Mary E Haywood; Orfeo Sbaizero; Matthew R G Taylor; Luisa Mestroni Journal: Front Physiol Date: 2019-11-28 Impact factor: 4.566
Authors: Aref Najafi; Martijn van de Locht; Maike Schuldt; Patrick Schönleitner; Menne van Willigenburg; Ilse Bollen; Max Goebel; Coen A C Ottenheijm; Jolanda van der Velden; Michiel Helmes; Diederik W D Kuster Journal: J Physiol Date: 2019-07-30 Impact factor: 5.182